Status:

RECRUITING

Knee Related Subchondral Bone Lesions Treated With IOBP

Lead Sponsor:

Arthrex, Inc.

Conditions:

Subchondral Cyst

Eligibility:

All Genders

18-60 years

Brief Summary

The study will be a prospective, multicenter clinical study evaluating clinical and patient reported outcome measures of subjects receiving IOBP® surgical technique using Angel cPRP and BMA processing...

Detailed Description

The study will be a prospective, multicenter, clinical study, enrolling both male and female patients. Subjects will be identified among the investigators' patient population scheduled for the IOBP® p...

Eligibility Criteria

Inclusion

  • Able to read, understand, sign and complete informed consent
  • Male or female subject between the ages of 18-60 years
  • Subject has had pain for greater than three months
  • Subjects with single SBP in tibia or femur confirmed by minimum 1.5T MRI (including coronal, axial, sagittal, lateral femur, and lateral tibia views) and are candidates for an IOBP® procedure
  • Subject has stable ligaments
  • Subject has neutral alignment (max 5° varus or valgus)
  • Subject has a VAS score greater than or equal to five
  • Subject is scheduled to undergo surgical intervention using IOBP®

Exclusion

  • Subject has diabetes Type I, Type II uncontrolled, or Type II insulin dependent
  • Subject has had lower extremity surgery within six months
  • Subject has had more than two prior surgical procedures in the operative leg
  • Subject has a neuromuscular condition
  • Subject has a current infection
  • Subject has a BMI \>35
  • Subject has subchondral bone collapse or Kellgren Lawrence grade IV osteoarthritis
  • Subject has joint surface collapse in late stage avascular necrosis
  • Subject has majority of pain associated with alternate conditions
  • Subject has had subchondral bone pathology caused by acute trauma
  • Subject is not neurologically intact.
  • Subject has history of invasive malignancy (except non-melanoma skin cancer)
  • Subject that has a planned or scheduled additional surgery within the course of the study (lower extremity)
  • Subject has an active substance abuse problem
  • Subject is currently taking narcotic pain medication
  • Subject is pregnant or planning to become pregnant
  • Subject is on worker's compensation
  • Subject has a concomitant procedure not including meniscectomy, synovectomy, chondroplasty, or removal of loose body
  • Inability to complete study requirements and follow-up visits
  • Subject that has a bone marrow aspiration that does not meet 60cc

Key Trial Info

Start Date :

November 17 2021

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

May 17 2027

Estimated Enrollment :

100 Patients enrolled

Trial Details

Trial ID

NCT05314608

Start Date

November 17 2021

End Date

May 17 2027

Last Update

December 5 2022

Active Locations (5)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 2 (5 locations)

1

University of Colorado Sports Medicine

Denver, Colorado, United States, 80222

2

Andrews Research and Education Foundation

Gulf Breeze, Florida, United States, 32561

3

TidalHealth Peninsula Regional, Inc.

Salisbury, Maryland, United States, 21801

4

The Ohio State University

Columbus, Ohio, United States, 43201